Screening for hepatitis among Mongolians in France
Part of Cancer, Digestive system, Infections clinical trials.
This study aims to screen for hepatitis B, C, and delta virus infections among the Mongolian community living in France. It offers free testing and will help connect those who test positive to appropriate care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are of Mongolian origin (born in Mongolia or of Mongolian descent).
- You are 15 years old or older.
- You live in France.
- If you are under 18, your parent or guardian agrees to your participation.
- You are not already being treated or followed for hepatitis B, C, or delta.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a group of people to measure small hepatitis B “viral RNA” signals in the blood. The goal is to see if these measurements could help researchers find a functional cure and better understand who may respond over time.
This trial is a screening study to find hepatitis B and C infections in the Chinese community in Milan. It involves a simple rapid blood test and a questionnaire to help improve awareness and prevention.
This study follows people with hepatocellular carcinoma (HCC), a type of liver cancer, to learn how it changes over time. It may help improve understanding of which patients benefit from different care approaches.
This study is testing a screening program for hepatitis C among people who inject drugs in Armenia, Colombia. It aims to find and help those who may have the virus but don't know it.
This trial looks at a simple blood test for hepatitis D infection in migrant and refugee communities. It aims to find out who might need treatment and improve care for this group.
This study looks at a step-by-step process to screen for hepatitis C, treat it, and help people clear the virus. If you meet the basic requirements, joining could help ensure you get evaluated and, if eligible, treated in a structured way.
Hear when a new HEPATITIS C (HCV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.